Ensysce Biosciences Announces Enrollment Completion for PF614-201 Clinical Study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/25/2026

1. SPY
2. AKAM
3. COST
4. META
5. NVDA
6. ZS
7. AWK
8. DRI
9. ULS
10. VEON

Go back to Ensysce Biosciences Announces Enrollment Completion for PF614-201 Clinical Study
(NASDAQ: ENSC) Delayed: 0.41 +0.01 (2.50%)
Previous Close $0.40    52 Week High $ 
Open $0.41    52 Week Low $ 
Day High $0.42    P/E N/A 
Day Low $0.40    EPS $ 
Volume 141,762